ULIANO, JACOPO

ULIANO, JACOPO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.002 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 2022 Mazzarella LCrimini EUliano JCorti CTrillo Aliaga PRepetto MAntonarelli GCriscitiello CCurigliano G. + Article (author) -
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 2022 Mazzarella, LGiugliano, FNicolo', ECrimini, EUliano, JCorti, CRepetto, MAntonarelli, GAscione, LVivanet, GCriscitiello, CCurigliano, G + Article (author) -
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis 2022 Giugliano, FedericaGalli, GiuliaCorti, ChiaraUliano, JacopoVivanet, GraziaCurigliano, GiuseppeConforti, Fabio + Article (author) -
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 2021 Giugliano, FCrimini, EUliano, JCorti, CRepetto, MAntonarelli, GVivanet, GCriscitiello, CCurigliano, G + Article (author) -
Characterization of low HER2 expressions in de-novo metastatic breast cancer 2021 Tarantino, PZagami, PGiugliano, FCrimini, ECorti, CUliano, JMorganti, SCriscitiello, CCurigliano, G + Article (author) -
Clinical development and current role of margetuximab for the treatment of breast cancer 2021 Uliano J.Morganti S.Giugliano F.Crimini E.Curigliano G. + Article (author) -
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review 2021 Trapani, DGiugliano, FUliano, JFerraro, ECriscitiello, CCurigliano, G + Article (author) -
Margetuximab for the treatment of HER2-positive metastatic breast cancer 2021 Morganti S.Uliano J.Giugliano F.Crimini E.Curigliano G. + Article (author) -
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 2021 Crimini E.Corti C.Repetto M.Giugliano F.Antonarelli G.Zagami P.Morganti S.Uliano J.Curigliano G. + Article (author) -
First line treatment of BRAF mutated advanced melanoma: Does one size fit all? 2021 Giugliano, FedericaCrimini, EdoardoZagami, PaolaUliano, JacopoCorti, ChiaraTrapani, DarioCurigliano, Giuseppe + Article (author) -